LONG-TERM SAFETY, TOLERABILITY, and EFFICACY of SUBCUTANEOUS EFGARTIGIMOD PH20 in PARTICIPANTS with GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS of the ADAPT-SC+ STUDY

Authors
Category Primary study
Conference54th Annual Conference of the Italian Society of Neurology
Year 2024
This article has no abstract
Epistemonikos ID: ffe086e0152d01e0950453344e136fa463b1c011
First added on: Jan 06, 2026